提供学术论文选刊润色服务
医学
医学
Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
99
天
An In Vitro Quantitative Systems Pharmacology Platform for Characterizing CD3-Bispecific Antibody-Mediated T-Cell Activation and Tumor Cell Cytotoxicity
作者Xuanzhen Yuan; Craig Thalhauser; Nasrin Afzal; Kristel Kemper; Guohua An; Tommy Li
作者单位1. Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, USA; 2. Genmab, Princeton, USA
100
天
Assessment of Sorbitol as a Pharmaceutical Excipient in Oral Liquid Pediatric Formulations Submitted to the U.S. FDA
作者Gelareh A. Abulwerdi; Brianna Cote; Susan Abdel-Rahman; Elimika Pfuma Fletcher; Gilbert J. Burckart
作者单位1. Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, USA
153
天
153
天
Updated Recommendations for the Bioanalysis of Antibody–Drug Conjugates (ADC) from the ADC working group of the AAPS Bioanalytical Community
作者Jim X. Shen; Robert Dodge; Shoshana Oberstein; Jennifer Cunliffe; Varun Ramani; Soumya Mohana Sundaram; Ines C. Santos; Chongwoo Yu; Sanjay L. Dholakiya; Seema Kumar; Xiaohui Sophia Xu; Sasha Fraser; Zeinab Mokhtari; Feng Yin; David G. Rizzo; Omar S. Barnaby; Honglue Shen; Dominic E. Warrino; Shivangi Awasthi; Krista Burke; Stephanie Schaffer; Alok Rathi
作者单位1. Bristol Myers Squibb, Lawrenceville, USA; 2. Princeton, USA; 3. Takeda Pharmaceutical Company Limited, Tokyo, Japan; 4. Novartis, Cambridge, USA; 5. Celerion, Lincoln, USA; 6. US Food and Drug Administration, Silver Spring, USA; 7. Pioneering Medicines at Flagship Pioneering Inc., Cambridge, USA; 8. Daiichi Sankyo Inc., Basking Ridge, USA; 9. Regeneron Pharmaceuticals Inc., Tarrytown, USA; 10. AbbVie Inc., North Chicago, Illinois, USA; 11. Amgen, USA; 12. Merck & Co., Inc., Rahway, USA; 13. KCAS Bio, Olathe, USA; 14. New Brunswick, USA; 15. BioAgilytix Boston, Boston, USA
137
天
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿96.4 天
中位数77 天